| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4aaf127397fd5f114d8bfee1628e155e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2009-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a81d565b4c8f3e876e55b4fb059ae87 |
| publicationDate |
2010-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20100086383-A |
| titleOfInvention |
Antibodies or antigen binding fragments that specifically bind to interleukin-15 or tumor necrosis factor |
| abstract |
The present invention provides antibodies or antibody fragments that specifically bind to interleukin-15 or tumor necrosis factor that are potent in treating autoimmune diseases. More specifically, the human interleukin-15 antibody or tumor necrosis factor antibody and fragments thereof of the present invention were obtained using phage display technology, and the human interleukin-15 antibody or tumor necrosis factor antibody and fragments thereof of the present invention are fully human antibodies. It is expected to be used as a medicament for treating inflammatory autoimmune diseases without immunogenicity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106661106-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106661106-B |
| priorityDate |
2009-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |